Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO7763505 in healthy volunteers and participants with stable coronary artery disease
NL-OMON60664Phase 1Completed
- Sponsor
- Roche
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of selnoflast in coronary arteriosclerosis (2 cohorts), sponsored by Roche. Started Mar 2026; status: completed.
02
Drugs
selnoflast
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on NL-OMON60664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60664.